Crypto payments to gray-market peptide vendors reach $32 million in Q1 2026

Chainalysis data cited by Bloomberg showed U.S. buyers shifted to crypto as some banks and card networks restricted payments, while stablecoins gained share among larger unregulated peptide vendors.

BTC

36d ago

Fact Check

The primary Chainalysis report directly confirms the $32 million Q1 2026 figure and the stablecoin dominance among larger (>$1K deposit) vendors. The Bloomberg article (via Yahoo Finance) confirms both the Chainalysis attribution/Bloomberg citation and that vendors demand crypto because traditional payment processors, banks, and card networks refuse to serve them. CryptoBriefing corroborates the stablecoin-versus-bitcoin shift for larger deposits. All material elements of the claim are supported by authoritative and corroborating sources.

Summary

Crypto payments to gray-market or unregulated peptide vendors reached $32 million in Q1 2026, according to Chainalysis data cited by Bloomberg, as U.S. consumers increasingly turned to digital assets after some banks and card networks restricted payments to certain suppliers. Chainalysis said the total was up 159% from $12 million in Q4 2025 and marked the sixth straight quarter of growth. The firm also said stablecoins overtook Bitcoin among vendors processing average deposits above $1,000, indicating a shift in payment behavior as the market expanded.

Terms & Concepts

Stablecoins: Crypto tokens designed to hold a steady value and often used for dollar-like settlement.
GLP-1 analogs: Compounds that mimic a hormone linked to appetite control and are discussed in the report as part of unbranded peptide demand.
Chainalysis: Blockchain analytics firm that tracked the crypto transaction flows referenced in the report.